Charlotte's Web Competitors

Abacus Health Products (OTCMKTS:ABAHF) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, valuation and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Abacus Health Products and Charlotte's Web, as provided by MarketBeat.

Charlotte's Web has a consensus price target of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher possible upside, analysts clearly believe Charlotte's Web is more favorable than Abacus Health Products.

Profitability

This table compares Abacus Health Products and Charlotte's Web's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Abacus Health Products and Charlotte's Web's revenue, earnings per share (EPS) and valuation.

Summary

Charlotte's Web beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Acreage (OTCMKTS:ACRGF) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, valuation and analyst recommendations.

Earnings & Valuation

This table compares Acreage and Charlotte's Web's revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Acreage and Charlotte's Web's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Acreage and Charlotte's Web, as provided by MarketBeat.

Acreage currently has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Charlotte's Web has a consensus price target of $7.25, indicating a potential upside of 85.76%. Given Acreage's higher possible upside, research analysts clearly believe Acreage is more favorable than Charlotte's Web.

Summary

Charlotte's Web beats Acreage on 2 of the 3 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation and Earnings

This table compares Applied Biosciences and Charlotte's Web's revenue, earnings per share and valuation.

Profitability

This table compares Applied Biosciences and Charlotte's Web's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent recommendations for Applied Biosciences and Charlotte's Web, as reported by MarketBeat.

Charlotte's Web has a consensus target price of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher probable upside, analysts clearly believe Charlotte's Web is more favorable than Applied Biosciences.

Summary

Charlotte's Web beats Applied Biosciences on 2 of the 2 factors compared between the two stocks.

Ayr Strategies (OTCMKTS:AYRSF) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation and Earnings

This table compares Ayr Strategies and Charlotte's Web's revenue, earnings per share and valuation.

Profitability

This table compares Ayr Strategies and Charlotte's Web's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent recommendations for Ayr Strategies and Charlotte's Web, as reported by MarketBeat.

Ayr Strategies presently has a consensus target price of $34.8571, indicating a potential upside of 63.96%. Charlotte's Web has a consensus target price of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher probable upside, analysts clearly believe Charlotte's Web is more favorable than Ayr Strategies.

Summary

Ayr Strategies beats Charlotte's Web on 2 of the 3 factors compared between the two stocks.

Can B (NASDAQ:CANB) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation and Earnings

This table compares Can B and Charlotte's Web's revenue, earnings per share and valuation.

Profitability

This table compares Can B and Charlotte's Web's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent recommendations for Can B and Charlotte's Web, as reported by MarketBeat.

Charlotte's Web has a consensus target price of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher probable upside, analysts clearly believe Charlotte's Web is more favorable than Can B.

Summary

Charlotte's Web beats Can B on 2 of the 2 factors compared between the two stocks.

Cansortium (OTCMKTS:CNTMF) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Analyst Recommendations

This is a breakdown of recent recommendations for Cansortium and Charlotte's Web, as reported by MarketBeat.

Cansortium presently has a consensus target price of $1.20, indicating a potential upside of 6.10%. Charlotte's Web has a consensus target price of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher probable upside, analysts clearly believe Charlotte's Web is more favorable than Cansortium.

Valuation and Earnings

This table compares Cansortium and Charlotte's Web's revenue, earnings per share and valuation.

Profitability

This table compares Cansortium and Charlotte's Web's net margins, return on equity and return on assets.

Summary

Charlotte's Web beats Cansortium on 2 of the 3 factors compared between the two stocks.